Magnolia Medical Technologies
Executivos
Veja o organograma con seus 38 executivos principais
Biografias mais buscadas da Magnolia Medical Technologies
- Gregory Bullington, Director and Chief Executive Officer
- Paul Enever, Director
- Marc-André Marcotte, Director
Criar um alerta
para seguir os movimentos de executivos da Magnolia Medical Technologies.
Biotecnologia
Magnolia Medical Technologies possui 2.290 concorrentes concorrentes Lonza (Suíça), Eurofins (Luxemburgo) e Adaptive Phage Therapeutics (Estados Unidos).
Popular M&A news in Biotecnologia
- Delphia Therapeutics acaba de anunciar uma arrecadação de fundos de 67 milhões de dólares. (publicado em 7 de maio de 2024).
- Karius acaba de anunciar uma arrecadação de fundos de 100 milhões de dólares. (publicado em 3 de maio de 2024).
- Transcarent acaba de anunciar uma arrecadação de fundos de 126 milhões de dólares. (publicado em 2 de maio de 2024).
Outros contatos sugeridos na indústria do Biotecnologia
Notícias
Últimos comunicados de imprensa de Magnolia Medical Technologies
- News & Media - Magnolia Medical
- News & Media - Magnolia Medical
- In Recognition of Sepsis Awareness Month, Magnolia Medical Intensifies Efforts to Combat the Clinical and Economic Risks of Sepsis Misdiagnosis - Magnolia Medical
- Magnolia Medical Expands Steripath® Micro Initial Specimen Diversion Device® (ISDD®) Product Family with New FDA 510(k) Clearance - Magnolia Medical
- The National Quality Forum (NQF) Endorses Centers for Disease Control and Prevention’s (CDC) New Blood Culture Contamination Quality Measure Copy - Magnolia Medical
- The National Quality Forum (NQF) Endorses Centers for Disease Control and Prevention’s (CDC) New Blood Culture Contamination Quality Measure - Magnolia Medical
- Large-scale, peer-reviewed study quantifies multiple devastating patient harms associated with blood culture contamination and most significantly, a 74% increase in risk of in-hospital patient mortality - Magnolia Medical
- Stanford Health Care Achieves Zero Blood Culture Contaminations and Near Elimination of False-Positive CLABSIs in Large-Scale Study Using the Steripath® Initial Specimen Diversion Device® - Magnolia Medical
- BD, Magnolia Medical Technologies Announce Commercial Collaboration to Help Reduce Blood Culture Contamination and Improve Testing Accuracy - Magnolia Medical
- Magnolia Medical Technologies Files for Permanent Injunction Against Infringing Kurin Lock Products - Magnolia Medical
- View more press releases Close
Redes sociais sobre Magnolia Medical Technologies
- Magnolia Medical Technologies na Wikipedia, Google News e Yahoo Finance
- Magnolia Medical Technologies na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Ovid Amadi 
Ligue para a Magnolia Medical Technologies em +1 888...
